Preclinical conference data for Oct. 17, 2023: AACR-NCI-EORTC
Oct. 17, 2023
New and updated preclinical data presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, by: Astrazeneca, Boundless Bio, Corbus Pharmaceuticals, Fusion Pharmaceuticals, Phio Pharmaceuticals, Scorpion Therapeutics.